Your session is about to expire
← Back to Search
Video-Based Intervention for BRCA Gene Mutations
Study Summary
This trial is studying how effective a video-based intervention is in encouraging participants' families to get tested for BRCA gene mutations. The goal is to reduce the cancer burden by allowing for risk management and reduction.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Arm A (video via text message)
- Group 2: Arm B (letter via standard U.S. mail)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age threshold for participation in this experiment limited to individuals 65 and older?
"The cutoff for age eligibility in this trial is 18 years old and the upper limit is 80."
Is it possible for me to partake in this research endeavor?
"This medical trial is seeking 200 participants, aged between 18 and 80 years of age, who are confirmed to have a BRCA 1 mutation. In addition to this pre-requisite, eligible individuals must receive the video message/family letter which will be offered out to family members."
Is there an ongoing recruitment process for this experiment?
"Absolutely, the information on clinicaltrials.gov confirms that recruitment is currently underway for this trial. It was first posted in April of 2018 and modified as recently as March 2022; it seeks to enrol 200 individuals at a single medical site."
What is the total enrollment number for this medical experiment?
"Affirmative. Records hosted on clinicaltrials.gov validate this medical trial is actively enrolling patients, with the initial post being made on April 5th 2018 and last updated March 2nd 2022. The research team seeks 200 participants from 1 site for their study."
Share this study with friends
Copy Link
Messenger